Founded in 2021, Bantham Radar Limited is a clinical informatics company dedicated to developing practical, effective tools that support better decision-making, reduce administrative burden, and improve the connection between clinicians and patients.
Our focus is on improving the delivery of frontline healthcare by making clinical processes more efficient, accessible, and responsive. We believe in applying the right technology in the right setting, not for its own sake, but to enable faster, more accurate, and more confident decision making.
Developed in close collaboration with GPs and dermatology specialists, our RADAR Case Management System (CMS) is designed to streamline the triage and diagnosis of dermatological conditions. It gives patients secure, direct access to primary care, while supporting clinicians with clear, structured clinical information without disrupting existing workflows.
Our approach is grounded in clinical realism. We understand the pressures faced by general practice and the importance of simple, safe, and scalable systems. By enabling GPs to do more with less, we aim to ease the strain on services, improve access for patients, and help build a more sustainable model of care.
Paul Daniel (Chairman) brings over 40 years of experience in investment banking, having spent 15 years at Morgan Stanley, rising to CoHead of Global Derivatives. His extensive expertise spans financial structuring, capital raising, and advisory services across a range of sectors.
Paul is both chairman of Bantham Radar Limited and a significant investor and shareholder in the business, having backed Bantham since early 2024. Paul also holds numerous directorships in related businesses, reflecting his ongoing commitment to strategic growth and financial innovation.
Edward Belgeonne (Co-Founder & CEO) is a seasoned technology entrepreneur with over 30 years’ experience in mobile, IT solutions, telematics and digital data capture for the B2B sector. As founding director of Bantham, he has leveraged his expertise to develop innovative digital solutions to drive substantial operational efficiencies across the healthcare sector, whilst also seeking to reduce the environmental impact of such activities.
Edward’s long-held passion for the environment was formally recognised when he won the Platinum Titan Business Award in 2021, underscoring his commitment to combining technological innovation and sustainability. Edward was awarded the UK National Winner of the Ernst & Young Entrepreneur of the Year Award for Science & Technology in 2007.
Robert Thomson (Director) is a seasoned executive with a distinguished track record in delivering technology-led solutions across the health and general insurance sectors. With over 13 years at IBM in a series of senior international roles, Robert consistently drove innovation and commercial growth on a global scale. He later joined The Huon Corporation as Global Sales and Marketing Director, where he spearheaded the company’s strategic direction and led it to a successful multi-million-pound trade sale.
In 2010, he became Managing Director at the Innovation Group, overseeing all aspects of the business and achieving major market wins across motor repair, subsidence, and software solutions.
In 2012, Robert was appointed Deputy CEO of the legal services division at Watchstone Plc. During his tenure, he led operational transformation, strategic acquisitions, and ultimately played a key role in the £650 million sale of the business to a leading law firm in 2016.
Robert currently serves as a Main Board Director at Bantham Radar and holds directorships with several other technology-focused companies, providing strategic guidance on innovation, growth, and governance.
Richard Bennett (Co-Founder and Head of Strategy) is an experienced technology leader with a strong track record of delivering transformative solutions to the NHS and the wider public sector.
Prior to establishing Bantham, he co-founded and was later appointed as managing director of, a highly successful, managed network services company, which, from a standing start, grew to 250 employees and over £35 million in annual revenue before being acquired by Capita plc.
Entrepreneurially minded, Richard has considerable experience across a variety of functions and remains passionate about using technology to drive meaningful operational improvements and improve outcomes for all stakeholders.
Fergus Vastenhout (Chief Systems Architect) brings over four decades of industry experience to the role. Fergus has spent the majority of his career working with smaller companies, drawn to the challenges and variety they offer. For more than 20 years, he has been a key figure within the Destiny/Inkwrx/Bantham group, initially joining as Lead Developer before naturally progressing into system architecture and design.
A seasoned full-stack developer, Fergus combines hands-on technical expertise with a deep understanding of system architecture. His skill set spans SQL Server, C#, Java, JavaScript, .NET, and React, alongside a readiness to master any new language or framework as needed. In addition to designing systems, he remains actively involved in coding and implementation, ensuring that his solutions are both robust and practically grounded. His enduring commitment to quality and innovation continues to shape the technical foundations of the organisation.
Vijay Relwani (Head of Technical Services) leads the development and quality assurance functions across the company’s digital and cloud-based solutions. Vijay has played a key role in the company’s growth and technical evolution. His technical leadership ensures that all new features are carefully planned, scoped, and implemented to meet client requirements while maintaining a high standard of performance and reliability.
With over 20 years of experience in digitally based solutions, Vijay brings deep technical knowledge and practical insight to his role. He oversees the end-to-end delivery process, from development to testing, ensuring that every release is robust, secure, and ready for deployment. His longstanding commitment to quality and continuous improvement underpins Bantham’s reputation for dependable, user-centred technology solutions.
Thomas Falcon (Head of Operations & Compliance) is an experienced MedTech executive with a proven track record in operational leadership, compliance, and strategic growth. Most recently Group Chief Operating Officer at OpenRad, he oversaw the post-merger integration of four entities across the UK and EU, scaling operations and securing FDA 510(k) clearance for US expansion while maintaining ISO 13485, MDR and ISO 27001 standards. Prior to this, he served as COO and then Head of Compliance at Visbion Ltd, where he led revenue model transformation, quality improvements, and investor relations—culminating in the successful sale of the business in 2022.
Thomas brings particular expertise in software-as-a-medical-device (SaMD) compliance, hybrid operations, and quality system development, including ISO 14971 and NHS DCB0129 clinical safety standards. With academic foundations in cognitive neuroscience and clinical psychology, he combines strategic insight with operational rigour. His leadership has consistently delivered growth, improved governance, and strong cross-functional collaboration, even during periods of regulatory upheaval and pandemic-related disruption.
Alistair Taylor-Sweet (Senior Computer Vision Engineer) is a computer vision and machine learning engineer with a background in full-stack software development and academic research. Previously based at the University of Manchester, he developed advanced machine learning models for breast cancer risk prediction and early detection using transformer-based architectures such as ViT and Swin. His work demonstrated notable improvements in predictive accuracy, earning him a presentation slot at SPIE 2025. Alistair has also led experimental research into dataset curation based on expert reader disagreement and has contributed extensively to visualisation and model evaluation tooling in Python.
Prior to his research role, Alistair worked as a software engineer at Omnibus, where he developed REST APIs, Angular applications, and database solutions using .NET, C#, and SQL. He holds an MSc in Advanced Computer Science from the University of Manchester and a first-class BSc in Computer Science from Manchester Metropolitan University. With a versatile technical skill set spanning C#, Python, machine learning frameworks, and DevOps tools, he combines academic rigour with commercial experience to solve complex, real-world problems.
Dr Natasha Kapur is a highly respected Consultant Dermatologist based in London, with broad expertise in both adult and paediatric skin conditions. After qualifying in 1992 from Charing Cross and Westminster Medical School, she trained at leading London institutions including St Mary’s, The Brompton, St John’s Institute of Dermatology, the Royal Free and UCLH. She has been at the forefront of introducing photodynamic therapy (PDT) in London teaching hospitals, following her award-winning Geoffrey Dowling Fellowship and research stint in Bern in 2001–02 . As Clinical Lead at The Whittington Hospital and Joint Teaching Lead in Dermatology at UCL Medical School, she also serves on the UCL admissions panel, mentoring medical students during their training.
Dr Kapur also acts as Principal Investigator in numerous national and international clinical trials, and regularly presents at national and international conferences, has authored book chapters and scientific papers, and continues to enhance patient care through community dermatology clinics and strong collaborations with general practitioners and interdisciplinary teams.
Professor Cyrus Kerawala is the Senior Head and Neck Surgeon at The Royal Marsden Hospital, specialising in mucosal cancer and salivary gland disease. He holds honours degrees in both medicine and dentistry from the University of London and completed specialist training in Oral and Maxillofacial surgery in the Northeast of England. He was appointed as a Consultant in 1999 and moved to The Royal Marsden in 2008, where until recently he served as Clinical Lead for the Head and Neck Unit and Lead Medical Examiner.
Professor Kerawala has authored a textbook in Maxillofacial Surgery, written numerous book chapters and over 120 peer-reviewed publications. He has presented over 130 papers at national and international meetings, and has been invited to lecture throughout Europe, America, the Middle East, Africa, Asia and Australia. He has contributed to numerous clinical guidelines, including being clinical lead and chair of two from NICE. His clinical and research interests include microvascular reconstruction, osteoradionecrosis, and minimally-invasive surgical techniques. He is a Past President of both the British Association of Oral and Maxillofacial Surgeons and the British Association of Head and Neck Oncologists, and he continues to advise national healthcare bodies on service quality and patient outcome
Dr Namid Stillman is Head of AI at Simudyne, leading the development of advanced simulationbased and deeplearning methods for industrial applications. An interdisciplinary computational scientist by training, he holds a PhD in Engineering Mathematics and has previously conducted postdoctoral research in drug discovery, material science and cell biology at the University of Bristol and University College London. At Simudyne since 2023, Dr Stillman drives R&D in artificial intelligence, deploying complex agentic models and generative techniques to tackle realworld challenges in finance and healthcare settings.
He is a prolific author of over 20 peerreviewed works spanning computational biology, nanomedicine, active matter, and AIdriven financial modelling.
Dr Stillman is also the author of Graph Neural Networks in Action, a practical guide to graphbased machine learning, and contributes actively to the broader AI community through conference talks and professional networks.
Professor Steve Williams is a leading authority in neuroimaging, with a research focus spanning the development of innovative imaging techniques from basic science through to clinical application. His work aims to establish brain imaging as a core tool in both neurology and psychiatry by advancing safe, non-invasive methods to measure brain structure, function, physiology, and metabolism. These techniques provide critical insights into brain biology, supporting more accurate diagnoses and informing the creation of new treatment approaches.
His current research includes the design of a dedicated, head-only MRI system and the development of faster, quieter imaging protocols tailored to the needs of complex and vulnerable patient groups. Professor Williams also heads the Department of Neuroimaging and the Centre for Neuroimaging Sciences at the South London and Maudsley Hospital, where he leads a multidisciplinary team at the forefront of clinical imaging research.
